Cite
HARVARD Citation
Ji, L. et al. (2023). Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 3 trial. Diabetes, obesity & metabolism. 25 (5), pp. 1229-1240. [Online].